[HTML] nih.gov

[HTML][HTML] Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models

L Han, Q Zhang, M Dail, C Shi, A Cavazos… - …, 2020 - ncbi.nlm.nih.gov
The pathogenesis of acute myeloid leukemia (AML) involves serial acquisition of mutations
controlling several cellular processes, requiring combination therapies affecting key …
被引用次数：99 相关文章

Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models

L Han, Q Zhang, M Dail, C Shi, A Cavazos… - …, 2020 - einstein.elsevierpure.com
The pathogenesis of acute myeloid leukemia (AML) involves serial acquisition of mutations
controlling several cellular processes, requiring combination therapies affecting key …

Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models

L Han, Q Zhang, M Dail, C Shi, A Cavazos… - …, 2020 - nchr.elsevierpure.com
The pathogenesis of acute myeloid leukemia (AML) involves serial acquisition of mutations
controlling several cellular processes, requiring combination therapies affecting key …

Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models

L Han, Q Zhang, M Dail, C Shi… - …, 2020 - khalifauniversity.elsevierpure.com
The pathogenesis of acute myeloid leukemia (AML) involves serial acquisition of mutations
controlling several cellular processes, requiring combination therapies affecting key …

Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models

L Han, Q Zhang, M Dail, C Shi, A Cavazos… - …, 2020 - pubmed.ncbi.nlm.nih.gov
The pathogenesis of acute myeloid leukemia (AML) involves serial acquisition of mutations
controlling several cellular processes, requiring combination therapies affecting key …

Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models.

L Han, Q Zhang, M Dail, C Shi, A Cavazos… - …, 2019 - europepmc.org
The pathogenesis of acute myeloid leukemia (AML) involves serial acquisition of mutations
controlling several cellular processes, requiring combination therapies affecting key …
[HTML] haematologica.org

[HTML][HTML] Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models

L Han, Q Zhang, M Dail, C Shi, A Cavazos… - …, 2020 - haematologica.org
The pathogenesis of acute myeloid leukemia (AML) involves serial acquisition of mutations
controlling several cellular processes, requiring combination therapies affecting key …

Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models

L Han, Q Zhang, M Dail, C Shi… - …, 2020 - mdanderson.elsevierpure.com
The pathogenesis of acute myeloid leukemia (AML) involves serial acquisition of mutations
controlling several cellular processes, requiring combination therapies affecting key …
[HTML] haematologica.org

[HTML][HTML] Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models

L Han, Q Zhang, M Dail, C Shi, A Cavazos… - …, 2020 - haematologica.org
The pathogenesis of acute myeloid leukemia (AML) involves serial acquisition of mutations
controlling several cellular processes, requiring combination therapies affecting key …